Tumgik
#Manik Reddy Pullagurla
news24fresh · 4 years
Text
Biophore India gets DCGI nod to manufacture COVID-19 drug Favipiravir
Biophore India gets DCGI nod to manufacture COVID-19 drug Favipiravir
[ad_1]
Biophore India Pharmaceuticals, a city-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture Favipiravir, a drug used in the finished formulation to treat mild to moderate cases of coronavirus (COVID-19).
The many questions about Favipiravir
Besides DCGI’s nod to produce the active pharmaceutical ingredient in India, it has been cleared for…
View On WordPress
0 notes